BactiQuant AS (OCSE:BACTIQ) Research & Development: kr0.00 Mil (TTM As of Dec. 2025)


OCSE:BACTIQ BactiQuant AS OCSE:BACTIQ
57 GF Score
Price kr2.48
GF Value kr2.37
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is BactiQuant AS Research & Development?

BactiQuant AS OCSE:BACTIQ -6.06% 57 Research & Development is kr0.00 Mil as of Dec. 2025. GuruFocus rates OCSE:BACTIQ with a GF Score™ of 57/100 and a GF Value™ of kr2.37 (Fairly Valued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. BactiQuant AS's Research & Development for the six months ended in Dec. 2025 was kr0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was kr0.00 Mil.

BactiQuant AS  (OCSE:BACTIQ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BactiQuant AS Research & Development Related Terms

BactiQuant AS Research & Development Historical Data

* Premium members only.

The historical data trend for BactiQuant AS's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BactiQuant AS Research & Development Chart

BactiQuant AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

BactiQuant AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OCSE:BACTIQ
57GF Score
BactiQuant AS OCSE:BACTIQ
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BactiQuant AS Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of kr0.00 Mil mean?
BactiQuant AS (OCSE:BACTIQ) has a Research & Development of kr0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on BactiQuant AS and its competitors.
Is BactiQuant AS's Research & Development too high?
BactiQuant AS's current Research & Development is kr0.00 Mil. Overall, BactiQuant AS has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BactiQuant AS's Research & Development compare to VLTO and ZWS?
BactiQuant AS's Research & Development of kr0.00 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Industrial Products company?
A good Research & Development depends on the Industrial Products industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on BactiQuant AS and its competitors. BactiQuant AS's current Research & Development is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BactiQuant AS stock overvalued right now?
Based on GuruFocus' analysis, BactiQuant AS (OCSE:BACTIQ) is currently considered Fairly Valued. The stock's GF Value™ is kr2.37, compared to a current price of kr2.48 — trading 4.6% above its estimated fair value. The current Research & Development is kr0.00 Mil. BactiQuant AS's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For BactiQuant AS (OCSE:BACTIQ), the current Research & Development is kr0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BactiQuant AS (OCSE:BACTIQ) Overvalued in 2026?

Based on GuruFocus' analysis, BactiQuant AS stock appears to be overvalued. The current stock price of kr2.48 is trading 4.6% above its estimated GF Value™ of kr2.37. GuruFocus considers BactiQuant AS to be Fairly Valued.

Key valuation signals for OCSE:BACTIQ:

  • Research & Development: kr0.00 Mil
  • GF Value™: kr2.37 vs. price of kr2.48 (4.6% above fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the OCSE:BACTIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BactiQuant AS Business Description

Address Blokken 75, Birkeroed, DNK, DK-3460
BactiQuant AS focuses on delivering technology that ensures optimum usage and handling of water around the world. The company's activities include the development, production, sale and service of BactiQuant Online and BactiQuant Mobile Lab with associated test kits/substrate for the quantification and detection of bacteria in water. Its segments are Aquaculture, Data Centres, Oil & Gas, Water Utility, Industry, and Pharma. The group's products are BQ Online 2.0 PRO, BQ Online, BQ Mobile Lab, and Analysis Kits.
57GF Score

Get the complete analysis for OCSE:BACTIQ

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.48
Price
kr2.37
GF Value